Chiral Catalysts
(3aS – 3’aS – 8aR – 8’aR)-2 – 2′-Cyclopentylidenebis[3a – 8a-dihydro-8H-indeno[1 – 2-d]oxazole]
Chiral Catalysts
(3aS – 3a’S – 8aR – 8a’R)-2 – 2′-Cyclohexylidenebis[8 – 8a-dihydro-3aH-indeno[1 – 2-d]oxazole]
Chiral Medicinal Intermediates
(3S)-3-[[(S)-1-Phenylethyl]amino]-1 – 3 – 4 – 5-tetrahydro-2H-1-benzazepin-2-one
Chiral Catalysts
(4R – 4’R – 5S – 5’S)-2 – 2′-(1-Methylethylidene)bis[4 – 5-dihydro-4 – 5-diphenyloxazole]
Chiral Catalysts
(4R – 4’R)-2 – 2′-[2-Phenyl-1-(phenylmethyl)ethylidene]bis[4-(1-methylethyl)-4 – 5-dihydrooxazole]
Chiral Catalysts
(4R – 4’R)-2 – 2′-Cyclopentylidenebis[4 – 5-dihydro-4-phenyloxazole]
Chiral Catalysts
(4R – 5R)-2 – 2-Dimethyl-? – ? – ?’ – ?’-tetra(1-naphthyl)-1 – 3-dioxolane-4 – 5-dimethanol
Chiral Catalysts
Chiral Catalysts
(4R – 5R)-N-(3 – 5-Bis(trifluoromethyl)phenyl)-4 – 5-diphenyl-4 – 5-dihydro-1H-imidazol-2-amine
Chiral Additives
Chiral Catalysts
(4R)-2-[2-(Diphenylphosphino)phenyl]-4 – 5-dihydro-4-phenyloxazole